NCT04671615 2025-12-10A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.PfizerCompleted559 enrolled 26 charts
NCT04735367 2025-12-09Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus LetrozolePfizerCompleted42 enrolled 7 charts
NCT06495164 2025-11-25A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast CancerPfizerActive not recruiting1 enrolled
NCT06086340 2025-11-18Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.PfizerCompleted779 enrolled 9 charts
NCT07096024 2025-08-28A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese MarketPfizerCompleted1,772 enrolled
NCT05399329 2025-07-11Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in JapanPfizerCompleted688 enrolled
NCT06307457 2025-06-29A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.PfizerCompleted604 enrolled 20 charts
NCT06962969 2025-06-10A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world DatabasePfizerNot yet recruiting1,000 enrolled
NCT04176354 2024-08-23Real-world Treatment Patterns and Effectiveness of Palbociclib and AI TherapyPfizerCompleted813 enrolled 11 charts
NCT05361655 2024-06-07Real-World Effectiveness of Palbociclib in Combination With an Aromatase InhibitorPfizerCompleted2,888 enrolled 17 charts
NCT06003114 2024-05-16A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other OrgansPfizerCompleted472 enrolled
NCT05584644 2023-12-19A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast CancerPfizerCompleted150 enrolled 26 charts
NCT04916509 2023-06-06Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf RegionPfizerCompleted258 enrolled
NCT05153135 2021-12-21Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 InhibitorsNovartisCompleted4,320 enrolled
NCT05141240 2021-12-16A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 InhibitorsNovartisCompleted4,650 enrolled